This Prior Information Notice is solely a general briefing about the upcoming tender between Amgros I/S in Denmark, Landspitali in Iceland, Sykehusinnkjøp in Norway, Region Skåne in Sweden and HUS Group in Finland. Regarding the section about Notice Information, please note that the tender notices for the pharmaceuticals included in the Joint Nordic Procurement 2028 will be published ultimo 2026, and the date listed under the section about Notice Information is only indicative. Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group will hold individual supplier meetings in August, September and October 2026 for the suppliers whom are interested. The meetings will provide general information about Joint Nordic Procurement process and setup. Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group encourages everyone who may participate in the Joint Nordic Tender 2028 to book a meeting. Further information about the supplier meetings and booking will be available on Amgros' Supplier and Tender Portal, Landspitali website, Sykehusinnkjøp website, Region Skåne website and HUS Group website no later than August 2026.

Joint Nordic Procurement 2028

The tender is a collaboration between Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group. The tender is expected to include selected dosage forms of the following ATC codes and in the collaborations: Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group: J01CA01, J01MA02, J01XA01 and J01CE01. Amgros, Landspitali, Sykehusinnkjøp and HUS Group: J01CR05, J01DC02, J01GB03, J01XD01 and J01DH02. Amgros, Landspitali, Sykehusinnkjøp and Region Skåne: N02BE01. Amgros, Landspitali and Sykehusinnkjøp: A04AA01, H02AB09, J02AC01, J05AB01 and L01BA01. The evaluation of the tender will be based on the following criteria: Price, Sustainability, and Security of Supply. The purchasing period is expected to run from 1 April 2028 to 31 March 2030, with the possibility of extension(s).